earnings
NASDAQ · BCDA
BioCardia, Inc.
Healthcare · Biotechnology
$1.10
Down-$0.02 (-1.82%)
Updated Sep 11, 2026, 10:46 PM
SID Score
4.3/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 8.58M
- P/E ratio
- -1,087.96
- Dividend yield
- 0.00%
- 52-week range
- $0.75 – $1.80
- Volume
- 79.96K
- Avg. volume
- 598.12K
Price performance
BCDA price history
1M range · 20 trading sessions · Daily adjusted prices
BCDA closed at $1.10 after 20 trading sessions, up 18.42% for the selected period.
- Last close
- $1.10
- Period change
- +18.42%
- Period low
- $0.93
- Period high
- $1.19
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 10, 2026 | $1.09 | $1.105 | $1.07 | $1.10 | 79.96K |
| Sep 9, 2026 | $1.1108 | $1.14 | $1.09 | $1.10 | 91.02K |
| Sep 8, 2026 | $1.09 | $1.135 | $1.08 | $1.11 | 130.31K |
| Sep 4, 2026 | $1.07 | $1.085 | $1.06 | $1.08 | 58.2K |
| Sep 3, 2026 | $1.12 | $1.13 | $1.07 | $1.09 | 169.6K |
| Sep 2, 2026 | $1.11 | $1.13 | $1.10 | $1.11 | 50.97K |
| Sep 1, 2026 | $1.13 | $1.13 | $1.08 | $1.10 | 69.29K |
| Aug 31, 2026 | $1.14 | $1.17 | $1.10 | $1.14 | 141.69K |
| Aug 28, 2026 | $1.17 | $1.1958 | $1.11 | $1.15 | 159.26K |
| Aug 27, 2026 | $1.18 | $1.23 | $1.17 | $1.17 | 211.55K |
| Aug 26, 2026 | $1.13 | $1.2101 | $1.10 | $1.19 | 247.12K |
| Aug 25, 2026 | $1.06 | $1.14 | $1.0201 | $1.13 | 354.25K |
| Aug 24, 2026 | $0.9951 | $1.06 | $0.9801 | $1.06 | 272.56K |
| Aug 21, 2026 | $0.973 | $1.02 | $0.956 | $1.01 | 82.46K |
| Aug 20, 2026 | $1.00 | $1.00 | $0.9501 | $0.9671 | 156.29K |
| Aug 19, 2026 | $0.98 | $1.03 | $0.9266 | $0.991 | 347.28K |
| Aug 18, 2026 | $0.9118 | $0.98 | $0.91 | $0.9754 | 280.62K |
| Aug 17, 2026 | $0.9632 | $0.97 | $0.903 | $0.94 | 180.24K |
| Aug 14, 2026 | $0.95 | $0.98 | $0.9103 | $0.9737 | 158.8K |
| Aug 13, 2026 | $0.88 | $0.9479 | $0.8521 | $0.9289 | 186.47K |
Latest BCDA news
The latest Smart Investors Daily articles mentioning BCDA.
Stock researchCompany · Earnings
Loading stock research…